Long-Acting Injectable Agents for HIV Prevention Research Overview

Background on the challenges of daily oral PrEP for HIV prevention and the potential of long-acting injectable agents like Rilpivirine (TMC278) in providing an alternative solution. The HPTN-076 study investigates the safety and acceptability of TMC278.LA for HIV pre-exposure prophylaxis. Key questi

0 views • 29 slides